nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.10.2008 | Original Paper

Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma

verfasst von: P. Saelee, S. Wongkham, V. Bhudhisawasdi, B. Sripa, S. Chariyalertsak, S. Petmitr

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To identify and characterize novel genetic alterations in hepatocellular carcinoma (HCC).

Methods

DNA was extracted from 29 HCC and corresponding normal tissues and amplified with 59 different 10-base arbitrary primers. A 550 bp DNA fragment amplified using primer Q-9 and which was present in 19 of 29 cases (66%) was cloned, sequenced, and compared with known nucleotide sequences deposited in Genome database, and quantified by real-time PCR.

Results

DNA alterations were found on chromosomes 5q34, 6p25.2 and 8q12.1 in 11 of 29 cases (38%), 7 of 29 cases (24%), and 12 of 29 cases (41%), respectively. Multivariate analysis showed that the allelic loss on chromosome 5q34 was an independent prognostic factor for poor survival of HCC patients, with the median survival time of 19 weeks for allelic loss versus 109 weeks for no allelic loss (P = 0.001).

Conclusions

This study indicates that allelic loss on chromosome 5q34 may be involved in the development of HCC and could be used as a prognostic indicator in HCC patients.

Achille A, Biasi MO, Zamboni G, Bogina G, Magalini AR, Pederzoli P, Perucho M, Scarpa A (1996) Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res 56:3808–3813PubMed

Badvie S (2000) Hepatocellular carcinoma. Postgrad Med J 76:4–11PubMedCrossRef

Buendia MA (2000) Genetics of hepatocellular carcinoma. Semin Cancer Biol 10:185–200PubMedCrossRef

Chariyalertsak S, Khuhaprema T, Bhudisawasdi V, Sripa B, Wongkham S, Petmitr S (2005) Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction. J Cancer Res Clin Oncol 131:821–828PubMedCrossRef

Chuensumran U, Wongkham S, Pairojkul C, Chauin S, Petmitr S (2007) Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma. World J Gastroenterol 13:2986–2991PubMed

de Juan C, Iniesta P, Vega FJ, Peinado MA, Fernandez C, Caldés T, Massa MJ, López JA, Sánchez A, Torres AJ, Balibrea JL, Benito M (1998) Prognostic value of genomic damage in non-small-cell lung cancer. Br J Cancer 77:1971–1977PubMed

de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C (1998) Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95:8847–8851PubMedCrossRef

De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL (1995) M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11:447–449PubMedCrossRef

Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503PubMedCrossRef

Elmileik H, Paterson AC, Kew MC (2005) Beta-catenin mutations and expression, 249serine p53 tumor suppressor gene mutation and hepatitis B virus infection in southern African Blacks with hepatocellular carcinoma. J Surg Oncol 91:258–263PubMedCrossRef

Faulkner SW, Leigh DA, Oosterhuis JW, Roelofs H, Looijenga LH, Friedlander ML (2000) Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model. Br J Cancer 83:729–736PubMedCrossRef

Fukai K, Yokosuka O, Imazeki F, Tada M, Mikata R, Miyazaki M, Ochiai T, Saisho H (2005) Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma. Liver Int 25:1209–1216PubMedCrossRef

Hosoe S, Ueno K, Shigedo Y, Tachibana I, Osaki T, Kumagai T, Tanio Y, Kawase I, Nakamura Y, Kishimoto T (1994) A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung. Cancer Res 54:1787–1790PubMed

Hsu LS, Lee HC, Chau GY, Yin PH, Chi CW, Lui WY (2006) Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Oncol Rep 15:507–511PubMed

Johannsdottir HK, Jonsson G, Johannesdottir G, Agnarsson BA, Eerola H, Arason A, Heikkila P, Egilsson V, Olsson H, Johannsson OT, Nevanlinna H, Borg A, Barkardottir RB (2006) Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors. Int J Cancer 119:1052–1060PubMedCrossRef

Kawakami K, Yasuda J, Shiraishi M, Kayama T, Doi K, Perucho M, Sekiya T (1998) Detection of DNA abnormalities by arbitrarily primed PCR fingerprinting: allelic losses in chromosome 10q in lung cancers. Biochem Biophys Res Commun 251:153–157PubMedCrossRef

Kohno T, Morishita K, Takano H, Shapiro DN, Yokota J (1994) Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting. Oncogene 9:103–108PubMed

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408PubMedCrossRef

Maeda T, Jikko A, Hiranuma H, Fuchihata H (1999) Analysis of genomic instability in squamous cell carcinoma of the head and neck using the random amplified polymorphic DNA method. Cancer Lett 26:183–188CrossRef

Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A (1997) Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 18:59–65PubMedCrossRef

Mendes-da-Silva P, Moreira A, Duro-da-Costa J, Matias D, Monteiro C (2000) Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma. Mol Pathol 53:184–187PubMedCrossRef

Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef

Murty VV, Reuter VE, Bosl GJ, Chaganti RS (1996) Deletion mapping identifies loss of heterozygosity at 5p15.1–15.2, 5q11 and 5q34–35 in human male germ cell tumors. Oncogene 12:2719–2723PubMed

Navarro JM, Jorcano JL (1999) The use of arbitrarily primed polymerase chain reaction in cancer research. Electrophoresis 20:283–290PubMedCrossRef

Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H, Ishizaki K (1993) Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 53:368–372PubMed

Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M, Ishizaki K (1994) Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54:3107–3110PubMed

Pakeetoot T, Punyarit P, Petmitr S (2007) Novel DNA amplification on chromosome 6q23–24 and 4p15.2 in breast cancer identified by arbitrarily primed polymerase chain reaction. J Exp Clin Cancer Res 26:253–259PubMed

Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA Cancer J Clin 49:33–64PubMedCrossRef

Peinado MA, Malkhosyan S, Velazquez A, Perucho M (1992) Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc Natl Acad Sci U S A 89:10065–10069PubMedCrossRef

Pongstaporn W, Rochanawutanon M, Wilailak S, Linasamita V, Weerakiat S, Petmitr S (2006) Genetic alterations in chromosome 10q24.3 and glutathione S- transferase Omega 2 gene polymorphism in ovarian cancer. J Exp Clin Cancer Res 25:107–114PubMed

Sheu JC, Lin YW, Chou HC, Huang GT, Lee HS, Lin YH, Huang SY, Chen CH, Wang JT, Lee PH, Lin JT, Lu FJ, Chen DS (1999) Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan. Br J Cancer 80:468–476PubMedCrossRef

Shin JH, Kang SM, Kim YS, Shin DH, Chang J, Kim SK, Kim SK (2005) Identification of tumor suppressor loci on the long arm of chromosome 5 in pulmonary large cell neuroendocrine carcinoma. Chest 128:2999–3003PubMedCrossRef

Singh KP, Roy D (2001) Identification of novel breast tumor-specific mutation(s) in the q11.2 region of chromosome 17 by RAPD/AP-PCR fingerprinting. Gene 269:33–43PubMedCrossRef

Tai AL, Yan WS, Fang Y, Xie D, Sham JS, Guan XY (2004) Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence. Cancer 100:1918–1927PubMedCrossRef

Welsh J, McClelland M (1990) Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 18:7213–7218PubMedCrossRef

Williams JG, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV (1990) DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res 18:6531–6535PubMedCrossRef

Xian ZH, Cong WM, Zhang SH, Wu MC (2005) Genetic alterations of hepatocellular carcinoma by random amplified polymorphic DNA analysis and cloning sequencing of tumor differential DNA fragment. World J Gastroenterol 11:4102–4107PubMed

Yakicier MC, Irmak MB, Romano A, Kew M, Ozturk M (1999) Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene 18:4879–4883PubMedCrossRef

Zhang X, Xu HJ, Murakami Y, Sachse R, Yashima K, Hirohashi S, Hu SX, Benedict WF, Sekiya T (1994) Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 54:4177–4182PubMed

Zhu GN, Zuo L, Zhou Q, Zhang SM, Zhu HQ, Gui SY, Wang Y (2004) Loss of heterozygosity on chromosome 10q22–10q23 and 22q11.2–22q12.1 and p53 gene in primary hepatocellular carcinoma. World J Gastroenterol 10:1975–1978PubMed

Titel: Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma
verfasst von: P. Saelee
S. Wongkham
V. Bhudhisawasdi
B. Sripa
S. Chariyalertsak
S. Petmitr
Publikationsdatum: 01.10.2008
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 10/2008
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-008-0379-1

Neu im Fachgebiet Onkologie

17.04.2024 | Mammakarzinom | Nachrichten

Springer Medizin

Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Chemotherapie mit Hindernissen

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2008

IIICS de novo glycosylated fibronectin as a marker for invasiveness in urothelial carcinoma of the urinary bladder (UBC)

Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays

Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group

Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy

FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas

Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma

Neu im Fachgebiet Onkologie

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Chemotherapie mit Hindernissen

Update Onkologie